Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Hospitaler/afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Søg efter ekspertise, navn eller tilknytning
It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia
Christian Brieghel
,
Caspar da Cunha-Bang
,
Jindrich Mourek
,
Lars Kjeldsen
,
Carsten Utoft Niemann
*
*
Corresponding author af dette arbejde
Afdeling for Blodsygdomme
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'It is feasible and safe to stop specialized follow-up of asymptomatic lower risk chronic lymphocytic leukemia'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Antimicrobial Therapy
12%
Chronic Lymphocytic Leukemia
100%
Clinical Assessment
12%
Clinical Evaluation
12%
Clinical Outcomes
12%
First Treatment
12%
Healthcare Resources
12%
Hospital Management
12%
Hospital Visits
12%
Intermediate Risk
25%
International Prognostic Index
12%
International Workshop
12%
Local Hospital
12%
Low Risk
100%
Overall Survival
25%
P-16
12%
Treatment Efficacy
12%
Universal Health Care
12%
Medicine and Dentistry
Antimicrobial Therapy
12%
B-Cell Chronic Lymphocytic Leukemia
100%
Clinical Assessment
12%
Clinical Trial
12%
Health Care
12%
Hospital Management
12%
Infection
12%
International Prognostic Index
12%
Overall Survival
25%
Universal Health Care
12%